Pharmaceuticals, Biotechnology and Life Sciences
Glenmark Pharmaceuticals said Tuesday it has bagged the final USFDA’s approval for its generic version of Mylan’s Olux-E Foam, Clobetasol Propionate Foam.
Longest survival follow-up from a pooled analysis of randomized Phase 3 trials of an Immuno-Oncology therapy in this setting demonstrated…
Daiichi Sankyo’s test of HER3 antibody drug conjugate U3-1402 data suggest that targeting HER3 with may be an effective treatment strategy irrespective of mechanism of resistance identified in the setting of EGFR TKI resistance, where new precision treatments are needed, said Helena Yu, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center, and a trial investigator.
Merck, a leading science and technology company, today announced the initiation of two global pivotal Phase III trials (EVOLUTION RMS 1 and 2) studying the efficacy and safety of evobrutinib, an oral, highly selective Bruton’s Tyrosine Kinase (BTK) inhibitor in adult patients with relapsing multiple sclerosis (RMS).
A new study shows the average annual cost for orphan drugs — $123,543 – is 25x more expensive than traditional…
Provides up to three years of interest only and extension of maturity date CHICAGO–(BUSINESS WIRE)–Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a…
First approval for Xeris is based on positive efficacy and safety results from multiple clinical studies GVOKE is the first…
DUBLIN–(BUSINESS WIRE)–The “Tourette’s Syndrome Drugs Market by Product and Geography – Global Forecast and Analysis 2019-2023” report has been added…
ABEC’s Flexible Manufacturing Platform doubles the production capacity of current flexible facilities BETHLEHEM, Pa.–(BUSINESS WIRE)–#abec—ABEC, a global provider of integrated…
ABEC Custom Single Run (CSR®) product line sets another industry benchmark in single-use productivity BETHLEHEM, Pa.–(BUSINESS WIRE)–#abec—ABEC, a global provider…